Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Implied Volatility Surging for Chesapeake Utilities Stock OptionsPhoto, wide shot, wide-angle lens,  Waste management company, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/e4828d98-af8d-41c8-b0c8-534bb658550b.png
Implied Volatility Surging for Chesapeake Utilities Stock Options

Investors in Chesapeake Utilities Corporation CPK need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $20.00 Put had some of the

Why VirTra Stock Deserves a Spot in Your Portfolio Right Now
Why VirTra Stock Deserves a Spot in Your Portfolio Right Now

VirTra, Inc. VTSI benefits from its military simulation training programs and extensive market reach, which have played an important part in the company's overall expansion. Given its robust growth

Pan American Silver (PAAS) Crossed Above the 20-Day Moving Average: What That Means for InvestorsPhoto, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Pan American Silver (PAAS) Crossed Above the 20-Day Moving Average: What That Means for Investors

From a technical perspective, Pan American Silver (PAAS) is looking like an interesting pick, as it just reached a key level of support. PAAS recently overtook the 20-day moving average, and this

Kimbell Royalty (KRP) Just Flashed Golden Cross Signal: Do You Buy?
Kimbell Royalty (KRP) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Kimbell Royalty (KRP) is looking like an interesting pick, as it just reached a key level of support. KRP recently overtook the 20-day moving average, and this suggests

Molina (MOH) Loses 18.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Molina (MOH) Loses 18.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Molina (MOH) has been beaten down lately with too much selling pressure. While the stock has lost 18.3% over the past four weeks, there is light at the end of the tunnel as it is now in oversold

IBM Concert Gains Traction: Can This AI-Driven Solution Aid the Stock?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
IBM Concert Gains Traction: Can This AI-Driven Solution Aid the Stock?

International Business Machines Corporation IBM recently announced that Deutsche Telekom AG DTEGY will deploy the IBM Concert solution to improve overall efficiency. This AI-powered automation

Visa (V) Is Considered a Good Investment by Brokers: Is That True?
Visa (V) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?
Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Ares Capital (ARCC) Is Considered a Good Investment by Brokers: Is That True?
Ares Capital (ARCC) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Is It Worth Investing in MicroStrategy (MSTR) Based on Wall Street's Bullish Views?
Is It Worth Investing in MicroStrategy (MSTR) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Brokers Suggest Investing in PulteGroup (PHM): Read This Before Placing a Bet
Brokers Suggest Investing in PulteGroup (PHM): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Wall Street Bulls Look Optimistic About Coupang (CPNG): Should You Buy?
Wall Street Bulls Look Optimistic About Coupang (CPNG): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Brokers Suggest Investing in Builders FirstSource (BLDR): Read This Before Placing a Bet
Brokers Suggest Investing in Builders FirstSource (BLDR): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views?
Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Bulls Look Optimistic About SkyWest (SKYW): Should You Buy?
Wall Street Bulls Look Optimistic About SkyWest (SKYW): Should You Buy?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is It Worth Investing in Palo Alto (PANW) Based on Wall Street's Bullish Views?
Is It Worth Investing in Palo Alto (PANW) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

POSCO Plans to Build Pilot Plant in Utah, Eyes Lithium ProductionPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
POSCO Plans to Build Pilot Plant in Utah, Eyes Lithium Production

Posco Holdings PKX has announced plans to develop a trial lithium processing plant in the United States in collaboration with Australia's Anson Resources. This is in sync with the company’s efforts

TSM Stock Hits 52-Week High: Is It Time to Book Profits or Buy More?Photo, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
TSM Stock Hits 52-Week High: Is It Time to Book Profits or Buy More?

Taiwan Semiconductor Manufacturing Company TSM, also known as TSMC, shares hit a 52-week high of $233.82 on July 2 and finally closed at $233.60, rising 18.2% year to date (YTD). This performance

PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?
PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?

Philip Morris International PM is redefining its profit engine through the accelerated growth of the smoke-free portfolio. In the first quarter of 2025, smoke-free products contributed 44% of the

Will The Decline in Legacy Drugs Pull Down BMY's Top Line?
Will The Decline in Legacy Drugs Pull Down BMY's Top Line?

Bristol Myers’ BMY legacy portfolio comprises Eliquis, Revlimid, Pomalyst, Sprycel and Abraxane.

Revenues for the Legacy Portfolio plunged 20% in the first quarter to $5.64 billion due to the

IART Stock May Rise on First Enrollment in AERA Pediatric Registry
IART Stock May Rise on First Enrollment in AERA Pediatric Registry

Integra LifeSciences Holding Corporation IART recently announced the enrollment of the first patient in the Acclarent AERA Pediatric Registry — a multi-center observational registry — designed to

FDA Grants Accelerated Approval to Regeneron's Blood Cancer DrugPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
FDA Grants Accelerated Approval to Regeneron's Blood Cancer Drug

Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory (R/R) multiple myeloma (MM).

The regulatory body granted accelerated

Taiwan Semiconductor Manufacturing Company Ltd. (TSM) Hits Fresh High: Is There Still Room to Run?Photo, wide shot, wide-angle lens,  Software company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/70b5df15-67cc-4a1b-af41-3596614daf77.png
Taiwan Semiconductor Manufacturing Company Ltd. (TSM) Hits Fresh High: Is There Still Room to Run?

Have you been paying attention to shares of TSMC (TSM)? Shares have been on the move with the stock up 15.4% over the past month. The stock hit a new 52-week high of $233.82 in the previous session

Red River Bancshares, Inc. (RRBI) Hit a 52 Week High, Can the Run Continue?
Red River Bancshares, Inc. (RRBI) Hit a 52 Week High, Can the Run Continue?

Shares of Red River Bancshares (RRBI) have been strong performers lately, with the stock up 12.2% over the past month. The stock hit a new 52-week high of $63 in the previous session. Red River

Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up

Teleflex TFX recently completed its previously announced acquisition of the majority of BIOTRONIK SE & Co. KG’s Vascular Intervention business. The acquisition significantly expands the company’s